More encouraging is the current clinical use of combination TNF-α with chemotherapeutic agents in the setting of hyperthermic isolated limb perfusion in limb-threatening soft tissue sarcomas and in-transit melanoma [3]. The gene discussed is TNF; the disease is melanoma.